Login

4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma (DDDD) to move its treatment for Parkinson’s disease into trials

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Ornella and J. Bradley Hall, CEO of Icon Capital Reserve, discuss innovative developments at the forefront of finance and technology.
00:10:00
Day in the Life: Dangote's Top Customer 2014 | Arvind Pathak - Managing Director of Dangote Cement Plc
00:10:00
Inflation Updates and Fed Rate Expectations: Market Reactions and Upcoming Data | Rob McDougle, Vice-President, Zhang Financial.
00:10:00
Ernie Burns Discusses Essential Budgeting Tips for a Comfortable Retirement
00:00:00
Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic
00:10:00
Ari Kahn and John Murcott Explore AI's Impact on Search and Merchandising | Ari Kahn, CEO , Bridgeline Digital Inc.
00:10:00
Safeguarding Digital Assets in an Evolving Threat Landscape | Bill Ford, CEO, General Atlantic.
00:10:00
SenesTech is committed to improving the health of the world|Joel Fruendt,Chief Executive Officer,SenesTech
00:10:00
Mario Stefano Discusses Omai Gold Mines' Historic Significance and Current Drilling Activities
00:10:00
Gold as an Inflation Hedge: Expert Insights | Edison Byzyka - Chief Investment Officer at Credent Wealth Management
00:10:00
Overview of BW's Successful Construction and Operation in Japan's Nuclear Sector
00:10:00
Dualite Microsphere Technology: What Is It, Described by Chase Corp engineer? | ADAM CHASE, CEO, Chase CorpCCF:ASQ

© 2017 - Neuhu+